Literature DB >> 8506386

Breaching the conformational integrity of the catalytic triad of the serine protease plasmin: localized disruption of a side chain of His-603 strongly inhibits the amidolytic activity of human plasmin.

A M Mhashilkar1, T Viswanatha, B A Chibber, F J Castellino.   

Abstract

Site-directed mutagenesis has been used to construct a cDNA that encodes a recombinant variant human plasminogen (hPg) containing a Pro-611-->Ile mutation (MrhPg). The mutein was expressed in recombinant baculovirus-infected Spodoptera frugiperda cells (IPLB-SF-21AE), and purified. After activation of this zymogen to its corresponding form of the serine protease plasmin (MrhPm), this latter enzyme was essentially inactive toward an amide plasmin substrate, most likely from alteration of the spatial relationships of the active-site His-603 to its partners of the catalytic triad, Asp-646 and Ser-741. Partial amidolytic activity of MrhPm was restored as a consequence of imidazole addition to the assay medium, due to an increase in the catalytic constant kcat of the enzyme. The serine protease inhibitor, diisopropylphosphofluoridate, when preincubated with MrhPm, did not inhibit restoration of its amidolytic activity with imidazole, whereas diisopropylphosphofluoridate did inhibit the amidolytic activity of MrhPm in the presence of imidazole. This result implies that His-603 directly influences the nucleophilic character of Ser-741. When imidazole as pretreated with alpha-N-tosyl-L-lysine chloromethyl ketone, the ability of this imidazole solution to restore amidolytic activity to MrhPm was eliminated, suggesting that N alpha-(p-tosyl)lysine chloromethyl ketone directs into the binding pocket a derivatized form of imidazole, which is ineffective as an His-603 substitute. These results indicate that the conformational reorientation of His-603 results in a malfunctional catalytic triad in the serine protease MrhPm, thus leading to an inactive enzyme despite the presence of all three essential amino acids of the catalytic triad. Addition of extramolecular imidazole restores a portion of the amidolytic activity of this mutant enzyme. These data also argue for an enzyme mechanism in which the active-center His-603 residue directly influences the nucleophilicity of the active-site Ser 741 residue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506386      PMCID: PMC46719          DOI: 10.1073/pnas.90.11.5374

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Direct Brønsted analysis of the restoration of activity to a mutant enzyme by exogenous amines.

Authors:  M D Toney; J F Kirsch
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

2.  Molecular cloning and characterization of a full-length cDNA clone for human plasminogen.

Authors:  M Forsgren; B Råden; M Israelsson; K Larsson; L O Hedén
Journal:  FEBS Lett       Date:  1987-03-23       Impact factor: 4.124

3.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.

Authors:  J W McLean; J E Tomlinson; W J Kuang; D L Eaton; E Y Chen; G M Fless; A M Scanu; R M Lawn
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

4.  The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin.

Authors:  K C Robbins; L Summaria; B Hsieh; R J Shah
Journal:  J Biol Chem       Date:  1967-05-25       Impact factor: 5.157

5.  Primary structure of peptides released during activation of human plasminogen by urokinase.

Authors:  B Wiman
Journal:  Eur J Biochem       Date:  1973-11-01

6.  Structures of the asparagine-289-linked oligosaccharides assembled on recombinant human plasminogen expressed in a Mamestra brassicae cell line (IZD-MBO503).

Authors:  D J Davidson; F J Castellino
Journal:  Biochemistry       Date:  1991-07-09       Impact factor: 3.162

7.  Plasminogens Tochigi II and Nagoya: two additional molecular defects with Ala-600----Thr replacement found in plasmin light chain variants.

Authors:  T Miyata; S Iwanaga; Y Sakata; N Aoki; J Takamatsu; T Kamiya
Journal:  J Biochem       Date:  1984-08       Impact factor: 3.387

8.  Primary structure of the B-chain of human plasmin.

Authors:  B Wiman
Journal:  Eur J Biochem       Date:  1977-06-01

9.  Engineering enzyme specificity by "substrate-assisted catalysis".

Authors:  P Carter; J A Wells
Journal:  Science       Date:  1987-07-24       Impact factor: 47.728

10.  Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.

Authors:  R C Wohl; L Arzadon; L Summaria; K C Robbins
Journal:  J Biol Chem       Date:  1977-02-25       Impact factor: 5.157

View more
  1 in total

1.  Structural investigations of the active-site mutant Asn156Ala of outer membrane phospholipase A: function of the Asn-His interaction in the catalytic triad.

Authors:  H J Snijder; J H Van Eerde; R L Kingma; K H Kalk; N Dekker; M R Egmond; B W Dijkstra
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.